EVgo initiated with an Equal Weight at Morgan Stanley
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Expedia Group, Inc. (EXPE) Had A Great Quarter, Says Jim Cramer
We recently published . Expedia Group, Inc. (NASDAQ:EXPE) is one of the stocks Jim Cramer recently discussed. Expedia Group, Inc. (NASDAQ:EXPE) is a travel services provider whose shares have gained 12.9% year-to-date. Over the past month, the shares have gained 14% after rising by 8.9% since the firm's second-quarter earnings. The results saw Expedia Group, Inc. (NASDAQ:EXPE) beat analyst estimates for revenue, earnings, and bookings. Naturally, when his co-host pointed out that Morgan Stanley had added the firm to a list of stocks that would end up suffering because of AI, Cramer was surprised as he commented: 'Expedia just had a great quarter, what are they talking about?' Pixabay/Public domain Here are Cramer's previous thoughts about Expedia Group, Inc. (NASDAQ:EXPE): 'Look, travel's been the biggest engine, okay. It's been the biggest engine of the economy in the last six months. And you can hurt it. I mean we obviously got, we also had some terrible instances with planes. But you can hurt travel and travel's really, . . . Someone upgraded Expedia yesterday, saying things were fine. But I do think that when you take the best bull market we have and you put chinks in it, we should then scramble. We scramble. Because we are running out of places that have bull markets.' While we acknowledge the potential of EXPE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
a day ago
- Business Insider
Why Morgan Stanley Increased Its Apple (AAPL) iPhone Production Estimate
Investment firm Morgan Stanley (MS) recently increased its estimate for Apple's (AAPL) iPhone production in the September quarter by 8%. Indeed, it is now forecasting 54 million units instead of 50 million for the tech giant. This change is due to stronger-than-expected iPhone sales in the June quarter, which brought inventory levels below normal and opened up more room for restocking. Analysts led by Erik Woodring highlighted that the increased production is focused entirely on the upcoming iPhone 16 and iPhone 16 Pro Max, with each contributing an extra 2 million units. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Interestingly, the team at Morgan Stanley is becoming more optimistic about Apple overall. In fact, it believes that many of the same positive trends from last year are still in place, such as longer iPhone upgrade cycles, strong demand buildup, and new product designs in the pipeline. It also notes that the peak risks from tariffs have likely passed. Additionally, Apple hasn't raised prices for its Services segment in two years, which is something the analysts view as an underused strategy that could drive future growth. As a result, they believe that earnings estimates are likely to trend higher, which historically has led to rallies for Apple stock. Looking further ahead, the analysts kept their iPhone 17 production forecast unchanged at 80 to 85 million units for the second half of Calendar Year 2025. This range is slightly below or roughly in line with the 84 million new-model iPhones produced in the second half of 2024. They also noted that iPhone production in the December quarter tends to be more volatile than in the September quarter. Indeed, excluding the COVID years (2020 and 2021), December builds have fluctuated from 35% to 71% higher than the previous quarter. Is Apple a Buy or Sell Right Now? Turning to Wall Street, analysts have a Moderate Buy consensus rating on AAPL stock based on 16 Buys, 11 Holds, and one Sell assigned in the past three months, as indicated by the graphic below. Furthermore, the average AAPL price target of $239.18 per share implies 3.5% upside potential.
Business Insider
a day ago
- Business Insider
CoreWeave (CRWV) Insiders Sell over $1B Worth of Shares as IPO Lock-Up Period Ends
CoreWeave (CRWV) insiders began selling shares today after the AI data center company's IPO lock-up period expired. As a result, this triggered more than $1 billion in block trades that were organized by Morgan Stanley (MS), JPMorgan Chase (JPM), and Goldman Sachs (GS). Among those selling was board director Jack Cogen, who sold nearly $300 million worth of stock. Interestingly, even though CoreWeave's stock had plunged by 35% in the previous two days due to disappointing second-quarter results, shares stabilized around the $100 level to close slightly up on the day. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The spike in trading activity happened because about 84% of CoreWeave's Class A shares became available for the first time since its IPO in March. According to the Financial Times, which cited sources close to the matter, banks scrambled on Thursday evening to arrange block trades as large as six to eight million shares. For context, block trades like these allow large investors to sell shares quietly, often at a discount, without overwhelming the market. Nevertheless, while CoreWeave has benefited from the AI infrastructure boom, concerns about its financial health are growing. Indeed, the company reported rising losses and surging operating expenses, which hit $1.2 billion in Q2 – almost four times higher than a year ago. On top of that, CoreWeave is facing investor pushback over its proposed $9 billion acquisition of Core Scientific (CORZ), as some shareholders of the target company have threatened to vote against it unless better terms are offered. It also doesn't help that, as of Thursday, 46% of CoreWeave's tradable shares were being shorted, thereby indicating that many investors are betting that the stock will continue to fall. Is CRWV a Good Stock to Buy? Turning to Wall Street, analysts have a Hold consensus rating on CRWV stock based on six Buys, 16 Holds, and two Sells assigned in the past three months, as indicated by the graphic below. Furthermore, the average CRWV price target of $115.29 per share implies 15.3% upside potential.
